Suzhou Abogen Biosciences Co., Ltd.

This study is testing a new experimental mRNA vaccine designed to prevent shingles, a painful rash caused by the reactivated chickenpox virus. It will involve about 300 healthy adults aged 40 and older who will receive two shots about two months apart. The main goals are to see h…

This study is testing a new, freeze-dried mRNA vaccine designed to protect adults aged 50 and older from Respiratory Syncytial Virus (RSV). Researchers are comparing two different dose levels against a placebo to see how well the vaccine triggers an immune response and how safe i…

This is an early-stage study to test the safety and immune response of a new, freeze-dried mRNA vaccine designed to protect against Respiratory Syncytial Virus (RSV). It will involve 96 healthy adults who will receive one injection of either the vaccine or a placebo. The main goa…

This is an early-stage study testing a new type of shingles vaccine that uses mRNA technology. It aims to see if the vaccine is safe and triggers a good immune response in 180 healthy adults aged 40 and older. Participants will receive two shots about two months apart, and resear…